MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) had its target price lifted by research analysts at Barclays from $41.00 to $59.00 in a research report issued on Tuesday, Marketbeat.com reports. The firm currently has an “equal weight” rating on the stock. Barclays‘s target price would indicate a potential upside of 2.36% from the company’s previous […]
Border to Coast Pensions Partnership Ltd grew its holdings in shares of Apple Inc. (NASDAQ:AAPL – Free Report) by 17.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,410,615 shares of the iPhone maker’s stock after purchasing an additional 208,731 shares […]
Whelan Financial trimmed its position in shares of Apple Inc. (NASDAQ:AAPL – Free Report) by 1.0% in the 1st quarter, Holdings Channel reports. The institutional investor owned 18,314 shares of the iPhone maker’s stock after selling 191 shares during the quarter. Apple accounts for 1.7% of Whelan Financial’s investment portfolio, making the stock its 9th […]
Real Estate Credit Investments Limited (LON:RECI – Get Free Report) announced a dividend on Thursday, September 14th, Upcoming.Co.Uk reports. Investors of record on Thursday, September 21st will be paid a dividend of GBX 3 ($0.04) per share on Friday, October 13th. This represents a yield of 2.3%. The ex-dividend date of this dividend is Thursday, […]
Ilmarinen Mutual Pension Insurance Co increased its position in shares of Apple Inc. (NASDAQ:AAPL – Free Report) by 8.3% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 785,000 shares of the iPhone maker’s stock after purchasing an additional 60,000 shares during the quarter. Apple […]